Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation

Cellular Signalling

Volumn 27, Issue 2, 2015, Pages 394-401

  Toma Jonik, Agnieszka ^a   Widlak, Wieslawa ^a   Korfanty, Joanna ^a   Cichon, Tomasz ^a   Smolarczyk, Ryszard ^a   Gogler Piglowska, Agnieszka ^a   Widlak, Piotr ^a   Vydra, Natalia ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Adhesion; Anchorage independent growth; Metastasis; Thermotolerance; Vinculin

Indexed keywords

ACTIN; FIBRONECTIN; HEAT SHOCK TRANSCRIPTION FACTOR 1; VINCULIN; DNA BINDING PROTEIN; HSF1 PROTEIN, MOUSE; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BINDING SITE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSKELETON; DISEASE MODEL; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; METASTASIS POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VCL GENE; ACTIN FILAMENT; ALLOTRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; FEMALE; GENETICS; MELANOMA; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; RNA INTERFERENCE; TEMPERATURE; TUMOR CELL LINE;

ANIMALIA;

ACTIN CYTOSKELETON; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TEMPERATURE; TRANSCRIPTION FACTORS; TRANSPLANTATION, HOMOLOGOUS; VINCULIN;

EID: 84918779651     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.11.029     Document Type: Article

References (44)

1. Akerfelt M., Trouillet D., Mezger V., Sistonen L. Ann. N. Y. Acad. Sci. 2007, 1113:15-27. 10.1196/annals.1391.005.
2. Anckar J., Sistonen L. Annu. Rev. Biochem. 2011, 80:1089-1115. 10.1146/annurev-biochem-060809-095203.
3. Calderwood S.K., Khaleque M.A., Sawyer D.B., Ciocca D.R. Trends Biochem. Sci. 2006, 31:164-172. 10.1016/j.tibs.2006.01.006.
4. Chiu C.-C., Lin C.-Y., Lee L.-Y., Chen Y.-J., Lu Y.-C., Wang H.-M., Liao C.-T., Chang J.T.-C., Cheng A.-J. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2011, 17:4629-4641. 10.1158/1078-0432.CCR-10-2107.
5. Chng K.R., Chang C.W., Tan S.K., Yang C., Hong S.Z., Sng N.Y.W., Cheung E. EMBO J. 2012, 31:2810-2823. 10.1038/emboj.2012.112.
6. Creekmore A.L., Silkworth W.T., Cimini D., Jensen R.V., Roberts P.C., Schmelz E.M. PLoS ONE 2011, 6:e17676. 10.1371/journal.pone.0017676.
7. Dai C., Whitesell L., Rogers A.B., Lindquist S. Cell 2007, 130:1005-1018. 10.1016/j.cell.2007.07.020.
8. Fang F., Chang R., Yang L. Cancer 2012, 118:1782-1794. 10.1002/cncr.26482.
9. Friedl P., Wolf K. Nat. Rev. Cancer 2003, 3:362-374. 10.1038/nrc1075.
10. Gabai V.L., Meng L., Kim G., Mills T.A., Benjamin I.J., Sherman M.Y. Mol. Cell. Biol. 2012, 32:929-940. 10.1128/MCB. 05921-11.
11. Golji J., Mofrad M.R.K. PLoS Comput. Biol. 2013, 9:e1002995. 10.1371/journal.pcbi.1002995.
12. Gu S., Papadopoulou N., Nasir O., Föller M., Alevizopoulos K., Lang F., Stournaras C. Mol. Med. Camb. Mass 2011, 17:48-58. 10.2119/molmed.2010.00120.
13. Hoang A.T., Huang J., Rudra-Ganguly N., Zheng J., Powell W.C., Rabindran S.K., Wu C., Roy-Burman P. Am. J. Pathol. 2000, 156:857-864. 10.1016/S0002-9440(10)64954-1.
14. Janus P., Pakuła-Cis M., Kalinowska-Herok M., Kashchak N., Szołtysek K., Pigłowski W., Widlak W., Kimmel M., Widlak P. Genes Cells Devoted Mol. Cell. Mech. 2011, 16:1168-1175. 10.1111/j.1365-2443.2011.01560.x.
15. Kabakov A.E., Malyutina Y.V., Latchman D.S. Radiat. Res. 2006, 165:410-423.
16. Khaleque M.A., Bharti A., Sawyer D., Gong J., Benjamin I.J., Stevenson M.A., Calderwood S.K. Oncogene 2005, 24:6564-6573. 10.1038/sj.onc.1208798.
17. Kubo M., Li T.-S., Kurazumi H., Takemoto Y., Ohshima M., Yamamoto Y., Nishimoto A., Mikamo A., Fujimoto M., Nakai A., Hamano K. PLoS ONE 2012, 7:e37934. 10.1371/journal.pone.0037934.
18. Kus-Liśkiewicz M., Polańska J., Korfanty J., Olbryt M., Vydra N., Toma A., Widłak W. BMC Genomics 2013, 14:456. 10.1186/1471-2164-14-456.
19. Lang B.J., Nguyen L., Nguyen H.C., Vieusseux J.L., Chai R.C.C., Christophi C., Fifis T., Kouspou M.M., Price J.T. Cell Stress Chaperones 2012, 17:765-778. 10.1007/s12192-012-0349-z.
20. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. J. Cell Biol. 2006, 172:973-981. 10.1083/jcb.200601018.
21. Lee Y.J., Lee H.J., Lee J.S., Jeoung D., Kang C.M., Bae S., Lee S.J., Kwon S.H., Kang D., Lee Y.S. Oncogene 2008, 27:2999-3009. 10.1038/sj.onc.1210966.
22. Liang P., MacRae T.H. J. Cell Sci. 1997, 110(Pt 13):1431-1440.
23. Mendillo M.L., Santagata S., Koeva M., Bell G.W., Hu R., Tamimi R.M., Fraenkel E., Ince T.A., Whitesell L., Lindquist S. Cell 2012, 150:549-562. 10.1016/j.cell.2012.06.031.
24. Mierke C.T., Kollmannsberger P., Zitterbart D.P., Diez G., Koch T.M., Marg S., Ziegler W.H., Goldmann W.H., Fabry B. J. Biol. Chem. 2010, 285:13121-13130. 10.1074/jbc.M109.087171.
25. Nagaraja G.M., Kaur P., Asea A. Curr. Mol. Med. 2012, 12:1142-1150.
26. Nakai A., Suzuki M., Tanabe M. EMBO J. 2000, 19:1545-1554. 10.1093/emboj/19.7.1545.
27. Nakamura Y., Fujimoto M., Fukushima S., Nakamura A., Hayashida N., Takii R., Takaki E., Nakai A., Muto M. Cancer Lett. 2014, 354:329-335. 10.1016/j.canlet.2014.08.029.
28. O'Callaghan-Sunol C., Sherman M.Y. Cell Cycle Georgetown Tex 2006, 5:1431-1437.
29. Page T.J., Sikder D., Yang L., Pluta L., Wolfinger R.D., Kodadek T., Thomas R.S. Mol. BioSyst. 2006, 2:627-639. 10.1039/b606129j.
30. Perez F.P., Moinuddin S.S., ul ain Shamim Q., Joseph D.J., Morisaki J., Zhou X. Curr. Aging Sci. 2012, 5:87-95.
31. Rodríguez Fernández J.L., Geiger B., Salomon D., Ben-Ze'ev A. Cell Motil. Cytoskeleton 1992, 22:127-134. 10.1002/cm.970220206.
32. Rupik W., Jasik K., Bembenek J., Widłak W. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2011, 159:349-366. 10.1016/j.cbpa.2011.04.002.
33. Santagata S., Hu R., Lin N.U., Mendillo M.L., Collins L.C., Hankinson S.E., Schnitt S.J., Whitesell L., Tamimi R.M., Lindquist S., Ince T.A. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18378-18383. 10.1073/pnas.1115031108.
34. Scott K.L., Nogueira C., Heffernan T.P., van Doorn R., Dhakal S., Hanna J.A., Min C., Jaskelioff M., Xiao Y., Wu C.-J., Cameron L.A., Perry S.R., Zeid R., Feinberg T., Kim M., Vande Woude G., Granter S.R., Bosenberg M., Chu G.C., DePinho R.A., Rimm D.L., Chin L. Cancer Cell 2011, 20:92-103. 10.1016/j.ccr.2011.05.025.
35. Solimini N.L., Luo J., Elledge S.J. Cell 2007, 130:986-988. 10.1016/j.cell.2007.09.007.
36. Tang D., Khaleque M.A., Jones E.L., Theriault J.R., Li C., Wong W.H., Stevenson M.A., Calderwood S.K. Cell Stress Chaperones 2005, 10:46-58.
37. Trinklein N.D., Murray J.I., Hartman S.J., Botstein D., Myers R.M. Mol. Biol. Cell 2004, 15:1254-1261. 10.1091/mbc.E03-10-0738.
38. Tsutsumi S., Beebe K., Neckers L. Future Oncol. Lond Engl. 2009, 5:679-688. 10.2217/fon.09.30.
39. Vydra N., Malusecka E., Jarzab M., Lisowska K., Glowala-Kosinska M., Benedyk K., Widlak P., Krawczyk Z., Widlak W. Cell Death Differ. 2006, 13:212-222. 10.1038/sj.cdd.4401758.
40. Vydra N., Toma A., Glowala-Kosinska M., Gogler-Piglowska A., Widlak W. BMC Cancer 2013, 13:504. 10.1186/1471-2407-13-504.
41. Vydra N., Toma A., Widlak W. Curr. Cancer Drug Targets 2014, 14:144-155. 10.2174/1568009614666140122155942.
42. Widłak W., Benedyk K., Vydra N., Głowala M., Scieglińska D., Małusecka E., Nakai A., Krawczyk Z. Acta Biochim. Pol. 2003, 50:535-541. (doi:035002535).
43. Xu W., Baribault H., Adamson E.D. Dev. Camb. Engl. 1998, 125:327-337.
44. Cichoń T., Jarosz M., Smolarczyk R., Ogórek B., Matuszczak S., Wagner M., Mitrus I., Sochanik A., Jazowiecka-Rakus J., Szala S. Acta Biochim. Pol. 2012, 59:377-381.